Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients (Q40620380)
Jump to navigation
Jump to search
scientific article published on April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients |
scientific article published on April 2000 |
Statements
1 reference
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients (English)
1 reference
Saito K
1 reference
Nakamura Y
1 reference
Aoyagi M
1 reference
Waga K
1 reference
Yamamoto K
1 reference
Aoyagi A
1 reference
Inoue F
1 reference
Nakamura Y
1 reference
Arai Y
1 reference
Tadokoro J
1 reference
Handa T
1 reference
Tsurumi S
1 reference
Arai H
1 reference
Kawagoe Y
1 reference
Gunnji H
1 reference
Kitsukawa Y
1 reference
Takahashi W
1 reference
Furusawa S
1 reference
1 April 2000
1 reference
1 reference
71
1 reference
3
1 reference
238-244
1 reference
Identifiers
1 reference